[EN] METHODS FOR THE PREVENTION AND TREATMENT OF MAJOR ADVERSE CARDIOVASCULAR EVENTS USING COMPOUNDS THAT MODULATE APOLIPOPROTEIN B [FR] MÉTHODES DE PRÉVENTION ET DE TRAITEMENT D'ÉVÈNEMENTS INDÉSIRABLES CARDIOVASCULAIRES MAJEURS À L'AIDE DE COMPOSÉS MODULANT L'APOLIPOPROTÉINE B
摘要:
本文提供了一般涉及预防、治疗和/或管理患有疾病或状况并处于主要不良心血管事件风险中的受试者的方法,例如家族性高胆固醇血症。本文还提供了涉及向患者施用具有核碱基SEQ ID NO: 247(例如,米泊美森)的反义寡核苷酸的治疗有效量的方法。
[EN] METHODS FOR THE PREVENTION AND TREATMENT OF MAJOR ADVERSE CARDIOVASCULAR EVENTS USING COMPOUNDS THAT MODULATE APOLIPOPROTEIN B [FR] MÉTHODES DE PRÉVENTION ET DE TRAITEMENT D'ÉVÈNEMENTS INDÉSIRABLES CARDIOVASCULAIRES MAJEURS À L'AIDE DE COMPOSÉS MODULANT L'APOLIPOPROTÉINE B
摘要:
本文提供了一般涉及预防、治疗和/或管理患有疾病或状况并处于主要不良心血管事件风险中的受试者的方法,例如家族性高胆固醇血症。本文还提供了涉及向患者施用具有核碱基SEQ ID NO: 247(例如,米泊美森)的反义寡核苷酸的治疗有效量的方法。
Antisense modulation of Notch (Drosophila) homolog 4 expression
申请人:Isis Pharmaceuticals Inc.
公开号:US20040077568A1
公开(公告)日:2004-04-22
Antisense compounds, compositions and methods are provided for modulating the expression of Notch (Drosophila) homolog 4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Notch (Drosophila) homolog 4. Methods of using these compounds for modulation of Notch (Drosophila) homolog 4 expression and for treatment of diseases associated with expression of Notch (Drosophila) homolog 4 are provided.